Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NFAT5 |
| Upstream (Parents) |
|---|
| (<<) SLC25A36 → NFAT5 |
| (<<) TES → NFAT5 |
| (<<) ATP1A1 → NFAT5 |
| (<<) STK24 → NFAT5 |
| (<<) PDGFA → NFAT5 |
| (<<) CACNB3 → NFAT5 |
| Downstream (Children) |
|---|
| NFAT5 → SMO (>>) |
| NFAT5 → GPR21 (>>) |
| NFAT5 → KCNK7 (>>) |
| NFAT5 → KRTAP9-4///KRTAP9-9 (>>) |
| NFAT5 → TMEM35 (>>) |
| NFAT5 → PCDHGA10 (>>) |
| NFAT5 → AKAP9 (>>) |
| NFAT5 → CTDSPL (>>) |
| NFAT5 → KHDC1L///KHDC1 (>>) |
| NFAT5 → STK24 (>>) |
| NFAT5 → SLC2A4 (>>) |
| NFAT5 → SNTB1 (>>) |
| NFAT5 → SPPL2B (>>) |
| NFAT5 → TSC2 (>>) |
| NFAT5 → MAP4 (>>) |
| NFAT5 → SP4 (>>) |
| NFAT5 → NFIX (>>) |
| NFAT5 → LOC729806 (>>) |
